Novaliq
PrivateLast Round
VC Round
Oct 11, 2018
Total Funding Raised
$17.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Novaliq operates in Healthcare & Life Sciences and is based in Heidelberg. Its latest recorded funding round was a VC Round in October 2018.
Novaliq is a biopharmaceutical company that develops and commercializes ocular therapeutics based on its proprietary EyeSol® water-free technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novaliq Comparables
Compare Novaliq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bausch + Lomb Corporation | 84% | |
| Harrow, Inc. | 79% | |
| Oyster Point Medical LLC | 77% |
For institutional investors. Book with your work email.
Novaliq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 11, 2018 | ||||
| VC Round | Apr 11, 2013 | ||||
| VC Round | May 4, 2012 | ||||
| VC Round | Jul 27, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novaliq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 51% MoM, reaching 5.6K.
- Jan 1, 2025
EyeSol technology drug approved in China in 2025.
For institutional investors. Book with your work email.
Novaliq Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novaliq's valuation, stock price, and market status.
Is Novaliq a public or private company?
Novaliq is a private company.
What is the current stock price of Novaliq?
Novaliq is a private company, so its shares have no public market price. Caplight tracks Novaliq's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novaliq worth (valuation)?
Valuation information for Novaliq is not publicly available.
Can I buy Novaliq stock?
Novaliq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novaliq's last funding round?
Novaliq's most recent funding round was VC Round on October 11, 2018.
Who are the main investors in Novaliq?
Key investors in Novaliq include dievini Hopp BioTech holding.
Will Novaliq IPO soon?
No public IPO plans have been announced for Novaliq.
How can I track Novaliq secondary market activity?
Caplight tracks bids, offers, and trades in Novaliq's shares on secondary markets.